

SI-BONE (NASDAQ:SIBN) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of SI-BONE (NASDAQ:SIBN) through any online brokerage.
Other companies in SI-BONE’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
SI-BONE has a consensus price target of $25.58.
The stock price for SI-BONE (NASDAQ: SIBN) is $23.52 last updated November 3, 2026 at 4:22 PM EST.
There are no upcoming dividends for SI-BONE.
SI-BONE does not have any upcoming earnings scheduled.
There is no upcoming split for SI-BONE.
SI-BONE is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the...